Location: Boston, MA
CIK: 0001703031 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value: $591M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SPRINGWORKS THERAPEUTICS INC | 7,281,307 | $197M | 33.2% | $21.68 | — | COM | 85205L107 |
| ARQT | ARCUTIS BIOTHERAPEUTICS, INC. | 3,979,292 | $119M | 20.1% | $26.87 | 0.0% | COM | 03969K108 |
| — | DICERNA PHARMACEUTICALS INC | 4,080,237 | $74.95M | 12.7% | $9.03 | — | COM | 253031108 |
| — | CONSTELLATION PHARMACEUTICALS INC. | 2,203,529 | $69.26M | 11.7% | $47.11 | — | COM | 210373106 |
| — | DYNAVAX TECHNOLOGIES CORP. | 8,730,707 | $30.82M | 5.2% | $3.58 | — | COM | 268158201 |
| REPL | REPLIMUNE GROUP INC | 2,838,968 | $28.3M | 4.8% | $17.53 | -15.0% | COM | 76029N106 |
| SVRA | SAVARA INC | 5,128,593 | $22.98M | 3.9% | $1.20 | +127.8% | COM | 805111101 |
| — | X4 PHARMACEUTICALS INC | 1,648,485 | $16.48M | 2.8% | $10.70 | — | COM | 98420X103 |
| — | MARINUS PHARMACEUTICALS INC | 5,942,735 | $12.06M | 2.0% | $6.30 | — | COM | 56854Q101 |
| — | APTINYX INC | 5,558,425 | $12.01M | 2.0% | $10.97 | — | COM | 03836N103 |
| — | SOLID BIOSCIENCES INC | 3,871,164 | $9.252M | 1.6% | $8.88 | — | COM | 83422E105 |